The McGowan Institute for Regenerative Medicine at the University of Pittsburgh seeks to be a national and international leader in regenerative medicine to address organ and tissue failure. McGowan researchers are dedicated to finding groundbreaking solutions in the fields of tissue engineering, cellular therapies, and medical devices to address human health issues of societal importance.
The McGowan Institute’s goal is to use the vast field of regenerative medicine to improve patient outcomes and quality of life. Our institute’s 250 interdisciplinary faculty members across the University of Pittsburgh’s campus and with other academic, industry and government partners are driven to conceptualize, innovate, develop, and commercialize regenerative medicine technologies for societal benefit.
Introduction to the McGowan Institute for Regenerative Medicine